The Weekly Roundup: October 13-17

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Dermatologists’ Role in Breast Cancer Awareness and Survivorship

Dermatologists enhance breast cancer care by managing skin issues, identifying genetic risks, and improving patient quality of life during treatment.

FDA Renews Funding for SELVA Study in Rare Lymphatic Disorder

Palvella surpassed enrollment goals in its Phase 3 SELVA trial, enrolling 51 patients at leading US vascular anomaly centers.

Belgian Study Maps True Cost Drivers in Psoriasis Care

Researchers found new patients incurred 40% higher consultation costs due to longer clinician interaction times.

Q&A: Reshaping the Retinoid Conversation with Deanne Mraz Robinson, MD, FAAD

Explore the latest advancements in retinoid technology with AlphaRet, enhancing skin tolerability and efficacy for diverse patient needs.

FDA Approves Cemiplimab as Adjuvant Immunotherapy for High-Risk CSCC

Regeneron's cemiplimab-rwlc gains FDA approval as the first immunotherapy for high-risk cutaneous squamous cell carcinoma, significantly improving disease-free survival.

From Practice to Policy: Clinicians Back Safe Step Act Protections

If passed, the Safe Step Act could reduce treatment delays by prohibiting step therapy for FDA-labeled, guideline-supported agents.

Case-Based Strategies for Optimizing AD Care

During a Case-Based Roundtable event, Naiem Issa, MD, PhD, guided colleagues through 3 complex atopic dermatitis cases, highlighting how modern topicals can deliver rapid and durable

Identifying Breast Issues Beyond the Skin

Dermatologists play a vital role in identifying breast cancer symptoms, bridging gaps in care for conditions like Paget disease and inflammatory breast cancer.

Targeted UVB Therapy Shows Promise for CTCL

A recent case reinforced excimer laser therapy as a precise, efficient, and well-tolerated approach in managing cutaneous T-cell lymphoma variants.

Unlocking the Skin’s Natural Healing Power

Yale researchers uncover how skin stem cells enhance healing during embryonic development, paving the way for advanced skin grafts and regenerative medicine.

Broadening the Therapeutic Horizon of Topical Dapsone Beyond Acne

Topical dapsone shows promise in treating various mucocutaneous diseases, including rosacea and neutrophilic dermatoses, with a favorable safety profile.

Adherence, Anxiety, and Access: Psoriasis Care Gets Personal

Mark Kaufmann, MD, discusses how patient realities shape psoriasis treatment choices.

Investigating a New 4% Glycyrrhetinic Acid Treatment Approach for SSD

A novel 4% glycyrrhetinic acid scalp gel shows rapid relief for mild to moderate seborrheic dermatitis, enhancing treatment options with herbal ingredients.

Young Adults’ Skin Care Habits Shaped by Social Media, Study Finds

Researchers found that while 96% of respondents use social media daily, most dermatologic information encountered online remains inaccurate or non-evidence-based.

From Consultation to Transformation: Kachiu Lee, MD, MPH, FAAD, Emphasizes Strategic Aesthetics at PDPA 2025

Kachiu Lee, MD, MPH, FAAD, shares insights on aesthetic dermatology at the 2025 PDPA Keystone, emphasizing trust and communication over technology for optimal results.

Phase 3 Ritlecitinib Trial Uses Synthetic Controls to Test Higher Dose Efficacy

The trial evaluates ritlecitinib's efficacy for severe alopecia areata, utilizing innovative external placebo controls for enhanced patient outcomes.

The Aesthetic Edge: October 2025

Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of October.

Guselkumab Demonstrates Robust Efficacy and Safety in Pediatric Psoriasis

Vimal Prajapati, MD, FRCPC, DABD, highlights guselkumab’s ability to achieve high levels of skin clearance in pediatric patients with moderate to severe plaque psoriasis.

Cutaneous Toxicities From Breast Cancer Therapies: What Dermatologists Need to Know

Explore the critical role of dermatologists in managing cutaneous toxicities from breast cancer therapies, enhancing patient quality of life and treatment outcomes.

Remote Assessment of AD Via Mobile App Shows High Agreement with Clinic Visits

Mobile app SkinTracker enhances atopic dermatitis care through remote assessments, proving effective and convenient for patients while saving costs.

Personalizing Acne Regimens: Balancing Efficacy, Tolerability, and Adherence

Through 3 complex cases, participants explored practical ways to integrate agents like clascoterone and tazarotene into daily practice.

FDA Alerts Clinicians to Serious Complications with Radiofrequency Microneedling Devices

FDA warns of serious risks associated with RF microneedling, urging patient education and careful provider training to ensure safety in aesthetic dermatology.

Strategies for Systemic Therapy for Moderate to Severe Psoriasis

Andrew Mastro, MS, PA-C, moderated a recent Dermatology Times Case-Based Roundtable event to present 3 complex cases of moderate to severe psoriasis treated with biologics.

Derm Dispatch: Lessons from the Eczema Community

The episode underscores the clinical value of listening to patient advocates who bring firsthand understanding of disease impact.

Bridging Personal and Clinical Experience to Better Support Patients With Breast Cancer

Explore essential insights on breast cancer diagnosis and dermatology, highlighting key practices for early detection and patient care.

Vishal A. Patel, MD, FAAD, FACMS, Discusses Cemiplimab’s Recent Approval for Adjuvant Treatment of High-Risk CSCC

Vishal A. Patel, MD, discusses cemiplimab's FDA approval as a groundbreaking adjuvant therapy for high-risk cutaneous squamous cell carcinoma patients.

Journal Digest: October 17, 2025

This review of the latest dermatologic studies highlights new research on hidradenitis suppurativa, including associated pediatric comorbidities, CO2 laser treatment, impact on sexual health, and more.

Nemolizumab Maintains Long-Term Efficacy in AD

In the ARCADIA LTE, nemolizumab maintained significant and progressive improvements in skin and itch outcomes for up to 104 weeks.

Guselkumab Improves Quality of Life in Pediatric Patients With Psoriasis and Their Caregivers

Vimal Prajapati, MD, FRCPC, DABD, highlights the durable efficacy of guselkumab, reassuring safety, and quality-of-life improvements in pediatric patients with moderate to severe plaque psoriasis.